Today marks the day when the FDA is scheduled to make a decision about a second new weight loss drug called QNEXA which is actually a combination of two older drugs. There was concern expressed by the expert panel about benefits versus risks. Previously, the FDA has asked for more data as was the case for lorcaserin-a different weight loss medicine which does not appear to have the same risks as QNEXA.

What will happen? Now that the physician community has a new medicine, the FDA could opt to require additional study which would further define the risks and the population who might be at risk. Given the 6 studies required of the maker of lorcaserin, there most probably will be a REMS AND a requirement for more study. The FDA could also reject the medicine at present and require studies to be conducted on the two FDA approved components. Time will tell and today appears to be the day.

Comments:

Information on this site reflects current information on medicines and is NOT medical advice. Talk to your doctor BEFORE making any changes, additions or deletions of any therapy. As noted in every previous edition of the Essential Guide to Prescription Drugs and the Essential Guide to Medical News, no claim is made that ALL known actions, uses, side effects, adverse effects, precautions or interactions for a drug are included in the information provided. While diligent care has been taken to ensure the accuracy of the information provided, the continued accuracy and currentness are ever subject to change